Consequently, in the TLR/NF-κB inhibition group, the inflammatory response in adipocytes was significantly suppressed, with reduced expression levels of TLR-4 and NF-κB-related proteins, thereby decreasing the production of inflammatory factors, which may help alleviate obesity-related chronic inflammation. Here, NFKB1 is linked to obesity due to melanocortin 4 receptor deficiency.